Further modes of action might include activation of the sympathetic nervous system and mast cells, vagal inhibition, prefrontal-amygdala complex and the immune system, downregulation of the hypothalamic corticotropin-releasing factor (CRF) system, the peripheral CRF system in inflammation, early life events and effects of depression [20]. The gene discussed is CRH; the disease is depressive symptom measurement.